You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

VITAMIN A PALMITATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Vitamin A Palmitate patents expire, and when can generic versions of Vitamin A Palmitate launch?

Vitamin A Palmitate is a drug marketed by Arcum, Banner Pharmacaps, and Bel Mar. and is included in five NDAs.

The generic ingredient in VITAMIN A PALMITATE is vitamin a palmitate. There are fifty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vitamin a palmitate profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for VITAMIN A PALMITATE?
  • What are the global sales for VITAMIN A PALMITATE?
  • What is Average Wholesale Price for VITAMIN A PALMITATE?
Summary for VITAMIN A PALMITATE
Drug patent expirations by year for VITAMIN A PALMITATE
Recent Clinical Trials for VITAMIN A PALMITATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Jiangsu Province Nanjing Brain HospitalPHASE4
Centre hospitalier universitaire de Qubec- Universit LavalNA
Centre de recherche du Centre hospitalier universitaire de SherbrookeNA

See all VITAMIN A PALMITATE clinical trials

US Patents and Regulatory Information for VITAMIN A PALMITATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arcum VITAMIN A PALMITATE vitamin a palmitate CAPSULE;ORAL 083311-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Banner Pharmacaps VITAMIN A PALMITATE vitamin a palmitate CAPSULE;ORAL 083981-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Arcum VITAMIN A PALMITATE vitamin a palmitate CAPSULE;ORAL 083321-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Banner Pharmacaps VITAMIN A PALMITATE vitamin a palmitate CAPSULE;ORAL 083948-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Vitamin A Palmitate

Last updated: August 4, 2025

Introduction

Vitamin A Palmitate, an esterified form of vitamin A, is a vital component in the pharmaceutical and nutrition industries. Its application spans from dietary supplements and fortification to ophthalmic formulations and dermatological products. As global health initiatives aim to combat vitamin A deficiency (VAD), understanding the current market landscape and future financial trajectory of Vitamin A Palmitate becomes crucial for stakeholders—manufacturers, investors, and policymakers alike.

This analysis explores the key market drivers, competitive landscape, regulatory environment, and forecasted trends that will shape the financial outcomes of Vitamin A Palmitate over the coming years.


Market Overview and Key Drivers

Global Prevalence of Vitamin A Deficiency

VAD remains a significant public health challenge, especially in developing regions such as Southeast Asia, Sub-Saharan Africa, and parts of Latin America. According to the World Health Organization (WHO), approximately 250 million children under five suffer from VAD, which can lead to blindness and increased mortality rates [1]. This health burden propels demand for vitamin A supplements, with Vitamin A Palmitate being the preferred ester form due to its stability and bioavailability.

Rising Consumer Awareness and Nutritional Fortification

The increasing awareness about the importance of nutrition, backed by government campaigns and the proliferation of health-conscious consumers, underpins the growth of fortified foods and supplements containing Vitamin A Palmitate. Regulatory mandates in regions like North America and Europe require food fortification and supplementation in at-risk populations, directly impacting market expansion.

Pharmaceutical and Cosmeceutical Applications

Beyond nutritional supplementation, Vitamin A Palmitate's role in ophthalmic solutions, dermatological preparations, and anti-aging formulations is expanding. These high-margin markets provide promising avenues for growth, particularly in developed economies where consumers seek advanced skincare and health products.


Market Segmentation and Regional Dynamics

By Application

  • Dietary Supplements: Constituting the largest segment due to VAD mitigation strategies.
  • Food Fortification: Increasingly adopted by governments and food manufacturers.
  • Pharmaceuticals: Use in corrective drugs for vitamin A deficiency-related conditions.
  • Cosmetics: Anti-aging and skin care products leveraging retinoid properties.

By End-User

  • Healthcare Providers & Governments: Focused on public health initiatives.
  • Food & Beverage Industry: Incorporating vitamin A into various products.
  • Pharmaceutical Companies: Developing targeted therapies.
  • Cosmetic Industry: Capitalizing on retinoid benefits.

Regional Insights

  • Asia-Pacific: Dominates the market owing to high VAD prevalence and expanding manufacturing capacities.
  • North America: Growth driven by dietary supplement demand and regulatory frameworks.
  • Europe: A mature market with increasing interest in dermatological products.
  • Latin America and Africa: Emerging markets with significant growth potential due to increasing health interventions.

Competitive Landscape

Major players include:

  • DSM Nutritional Products
  • BASF SE
  • Zhejiang Medicine Co., Ltd.
  • Yunnan Baiyao Group Co., Ltd.
  • Zhejiang Medicine Co., Ltd.

These firms compete based on product quality, production capacity, cost efficiency, and regulatory compliance. Innovation in extraction and stabilization techniques, such as nanoemulsions and encapsulation, enhances product efficacy and shelf life.


Regulatory Environment and Impact

Regulations at regional and global levels influence market dynamics:

  • FDA (U.S.): Approves dietary supplements and sets safety standards.
  • EFSA (Europe): Assesses safety and nutritional claims.
  • WHO & FAO: Recommend fortification standards and VAD intervention strategies.

Stringent regulations on food fortification and supplement safety can create barriers to entry but also ensure market integrity and consumer trust. Emerging regulations promoting bioequivalence and sustainability can further shape manufacturing practices and cost structures.


Market Challenges and Risks

  • Regulatory Hurdles: Complex approval pathways may delay product launches.
  • Price Volatility: Raw material cost fluctuations impact profit margins.
  • Competition from Synthetic Alternatives: Increasing interest in alternative vitamin A sources may challenge traditional producers.
  • Supply Chain Disruptions: Political instability and pandemic-related logistic constraints affect raw material supply and distribution.

Financial Trajectory and Forecasts

Market Size and Growth Projections

The global Vitamin A Palmitate market was valued at approximately USD 350 million in 2022, with a compound annual growth rate (CAGR) projected at 6-8% through 2030. Driven by increasing public health initiatives, fortified food demand, and expanding pharmaceutical applications, the market is poised for steady growth.

Revenue Drivers

  • Growing adoption in emerging markets for VAD prevention.
  • Expansion of the cosmetic industry with retinoid-based skincare products.
  • Innovation in drug delivery systems improving bioavailability and consumer appeal.

Investment Outlook

Investors are expected to favor companies with robust research pipelines, cost-efficient manufacturing, and strong regional distribution networks. Mergers and acquisitions are likely as major firms seek to consolidate their market position and diversify product portfolios.

Pricing Trends

Prices for raw materials like retinyl palmitate are influenced by palm oil prices (since palm oil derivatives are primary sources), global demand, and supply chain factors. Advances in biosynthesis and recombinant technology may reduce costs over time, fostering price stability.


Future Market Opportunities

  • Bioengineered Production: Synthetic biology techniques could lower costs and improve sustainability.
  • Expanded Fortification Programs: Governments' increasing commitment to VAD eradication provides a sustained demand pipeline.
  • New Delivery Platforms: Nanoemulsion and liposomal formulations can enhance bioavailability, commanding premium pricing.
  • Regulatory Harmonization: Global alignment could streamline cross-border trade and accelerate market entry for new products.

Key Market Trends to Watch

  • Adoption of plant-based and sustainable sources.
  • Integration of Vitamin A Palmitate in personalized nutrition.
  • Use in combination therapies for skin and eye health.
  • Development of sustainable manufacturing practices aligning with ESG standards.

Key Takeaways

  • The Vitamin A Palmitate market exhibits robust growth driven by global health initiatives targeting VAD and expanding applications in pharmaceuticals and cosmetics.
  • Regional disparities highlight significant opportunities in Asia-Pacific, with emerging markets in Latin America and Africa offering high growth potential.
  • Innovation in bioengineering and delivery systems can create premium market segments and enhance margins.
  • Regulatory landscapes are pivotal; harmonization and compliance will be critical for global expansion.
  • Investors should monitor raw material prices, technological advancements, and policy developments to capitalize on market opportunities.

FAQs

1. What are the main factors driving demand for Vitamin A Palmitate?
The main factors include global efforts to eradicate vitamin A deficiency, growing use in dietary supplements and fortified foods, and expanding applications in ophthalmic and dermatological pharmaceuticals.

2. How does regional regulation affect the Vitamin A Palmitate market?
Stringent safety and efficacy standards influence manufacturing practices, product approval timelines, and market entry costs, shaping regional competition and innovation.

3. What technological innovations are impacting the production of Vitamin A Palmitate?
Advances include biosynthetic methods, nanoencapsulation, and sustainable extraction techniques, which improve product quality, bioavailability, and environmental footprint.

4. What are the major risks facing stakeholders in this market?
Price volatility of raw materials, regulatory barriers, supply chain disruptions, and competition from alternative sources are primary risks.

5. How is sustainability influencing the future of Vitamin A Palmitate manufacturing?
Sustainable sourcing, greener extraction processes, and eco-friendly packaging are gaining importance, aligning with global ESG trends and consumer preferences.


Sources

[1] WHO. Vitamin A deficiency. World Health Organization, 2021.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.